2023年　論文

2023 論文

1	Agreement regarding overcoming hypertension in the Asian Hypertension Society Network 2022. Hoshide S, Yamamoto K, Katsurada K, Yano Y, Nishiyama A, Wang J, Narasingan S N, Verma N, Erwinanto E, Turana Y, Ihm S, Park S, Nik Sherina H, Chia Y, Unurjargal T, Siddique S, D Ona I, enketasubramanian N, Teo B W, Constantine G, Kao H, Hung C, Sukonthasarn A, Kunanon S, Van Minh H, Kario K, Node K, Itoh H, Rakugi H. Hypertens Res. 2023 Jan;46(1):3-8. doi: 10.1038/s41440-022-00994-1. Epub 2022 Oct 14.
2	Simultaneous SGLT2 inhibition and caloric restriction improves insulin resistance and kidney function in OLETF rats. Cornejo MA, Jardines E, Nishiyama A, Nakano D, Ortiz R M. Mol Cell Endocrinol. 2023 Jan 15;560:111811. doi: 10.1016/j.mce.2022.111811. Epub 2022 Oct 29.
3	(Pro)renin receptor promotes colorectal cancer progression through inhibiting the NEDD4L-mediated Wnt3 ubiquitination and modulating gut microbiota. Wang J, Ding Y, Li D, Zhu N, Nishiyama A, Yuan Y. Cell Commun Signal. 2023 Jan 3;21(1):2. doi: 10.1186/s12964-022-01015-x. Epub 2022 Oct 14.
4	Contributions of renal water loss and skin water conservation to blood pressure elevation in spontaneously hypertensive rats. Ogura T, Kitada K, Morisawa N, Fujisawa Y, Kidoguchi S, Nakano D, Kobara H, Masaki T, Titze J, Nishiyama A. Hypertens Res. 2023 Jan;46(1):32-39. doi: 10.1038/s41440-022-01044-6. Epub 2022 Oct 14.
5	Vasoactive intestinal peptide blockade suppresses tumor growth by regulating macrophage polarization and function in CT26 tumor-bearing mice. Kittikulsuth W, Nakano D, Kitada K, Uyama T, Ueda N, Asano E, Okano K, Matsuda Y, Nishiyama A. Sci Rep. 2023 Jan 17;13(1):927. doi: 10.1038/s41598-023-28073-6.
6	Prologue: Special Spotlight Issue on Japan. Yano Y, Nishiyama A, Ishimitsu T, Kashihara N, Rakugi H, Tamura K, Itoh H, Tsuchihashi T, Sakima A, Arima H, Matayoshi T, Imai Y, Miura K, Hisamatsu T, Asayama K, Ohkubo T, Node K, Kario K. J Hum Hypertens. 2021 Aug 2. doi: 10.1038/s41371-021-00589-2.
7	Blood pressure control with renin-angiotensin system inhibitors in hypertension patients with cancer - good or bad? Kidoguchi S, Nishiyama A. Hypertens Res. 2022 Nov 29. doi: 10.1038/s41440-022-01110-z. Online ahead of print.
8	Mapping the protein binding site of the (pro)renin receptor using in silico 3D structural analysis. Ebihara A, Sugihara D, Matsuyama M, Suzuki-Nakagawa C, Nurun Nabi A H M, Nakagawa T, Nishiyama A, Suzuki F. Hypertens Res. 2022 Dec 9. doi: 10.1038/s41440-022-01094-w. Online ahead of print.
9	Economic evaluation of a new blood pressure target for hypertensive patients in Taiwan. Minegishi S, Nishiyama A. Hypertens Res. 2023 Jan 5. doi: 10.1038/s41440-022-01125-6. Online ahead of print.
10	Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats. Rodriguez-Ortiz C J, Thorwald M A, Rodriguez R, Mejias-Ortega M, Kieu Z, Maitra N, Hawkins C, Valenzuela J, Peng M, Nishiyama A, Ortiz R M, Kitazawa M. Clin Exp Pharmacol Physiol. 2022 Nov 18. doi: 10.1111/1440-1681.13738. Online ahead of print.
11	The Renin-Angiotensin-Aldosterone System in Metabolic Diseases and Other Pathologies Rudy M Ortiz , Ryousuke Satou , Jia L Zhuo , Akira Nishiyama Int J Mol Sci. 2023 Apr 18;24(8):7413. doi: 10.3390/ijms24087413.
12	Possible contribution of phosphate to the pathogenesis of chronic kidney disease in dolphins Nourin Jahan , Hiroyuki Ohsaki , Kiyoko Kaneko , Asadur Rahman , Takeshi Nishiyama , Makoto Koizumi , Shuichiro Yamanaka , Kento Kitada , Yuki Sugiura , Kenji Matsui , Takashi Yokoo , Takayuki Hamano , Makoto Kuro-O , Takuya Itou , Miwa Suzuki , Keiichi Ueda , Akira Nishiyama Sci Rep. 2023 Mar 29;13(1):5161. doi: 10.1038/s41598-023-32399-6.
13	Comparison of endoscopic closure versus non-closure for post-gastric endoscopic submucosal dissection artificial floor in antithrombotic therapy: a propensity score-matched analysis Nobuya Kobayashi , Hideki Kobara , Noriko Nishiyama , Joji Tani , Taiga Chiyo , Kazuhiro Kozuka , Naoya Tada , Takanori Matsui , Shintaro Fujihara , Tatsuo Yachida , Koji Fujita , Akihiro Kondo , Keiichi Okano , Akira Nishiyama , Tsutomu Masaki Ann Gastroenterol. 2023 Mar-Apr;36(2):178-184. doi: 10.20524/aog.2023.0771. Epub 2023 Jan 2.
14	Effects of a monoclonal antibody against (pro)renin receptor on gliomagenesis Takeshi Fujimori , Yuki Shibayama , Takahiro Kanda , Kenta Suzuki , Daisuke Ogawa , Ryou Ishikawa , Kyuichi Kadota , Toru Matsunaga , Takashi Tamiya , Akira Nishiyama , Keisuke Miyake Sci Rep. 2023 Jan 16;13(1):808. doi: 10.1038/s41598-023-28133-x.
15	Potential Impact of Non-Steroidal Mineralocorticoid Receptor Antagonists in Cardiovascular Disease Asadur Rahman, Nourin Jahan, Md Tanvir Rahman, Akira Nishiyama Int J Mol Sci. 2023 Jan 18;24(3):1922. doi: 10.3390/ijms24031922.
16	Possible renoprotective mechanisms of SGLT2 inhibitors Akira Nishiyama, Kento Kitada Front Med (Lausanne). 2023 Mar 9;10:1115413. doi: 10.3389/fmed.2023.1115413. eCollection 2023.
17	Revisiting blood pressure and body fluid status Kento Kitada, Akira Nishiyama, Clin Sci (Lond). 2023 May 18;137(9):755-767. doi: 10.1042/CS20220500.
18	Future Prospects of Onco-Hypertension Shintaro Minegishi, Akira Nishiyama, Yuichiro Yano, Koichi Node; JSH Working Group Onco-Hypertension Hypertension. 2023 Jul;80(7):e123-e124. doi: 10.1161/HYPERTENSIONAHA.123.21011. Epub 2023 May 11.
19	Association of cancer with the risk of developing hypertension Hajime Nagasawa, Hidehiro Kaneko, Yuta Suzuki, Akira Okada, Katsuhito Fujiu, Norifumi Takeda, Hiroyuki Morita, Akira Nishiyama, Yuichiro Yano, Koichi Node, Anthony J Viera, Robert M Carey, Suzanne Oparil, Hideo Yasunaga, Rhian M Touyz, Issei Komuro Eur Heart J Qual Care Clin Outcomes. 2023 Jun 15;qcad036. doi: 10.1093/ehjqcco/qcad036. Online ahead of print.